nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—Carboplatin—ovarian cancer	0.455	1	CbGbCtD
Octreotide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000305	0.00062	CcSEcCtD
Octreotide—Weight decreased—Epirubicin—ovarian cancer	0.000305	0.000619	CcSEcCtD
Octreotide—Hyperglycaemia—Epirubicin—ovarian cancer	0.000304	0.000617	CcSEcCtD
Octreotide—Cough—Docetaxel—ovarian cancer	0.000304	0.000617	CcSEcCtD
Octreotide—Insomnia—Paclitaxel—ovarian cancer	0.000303	0.000615	CcSEcCtD
Octreotide—Pneumonia—Epirubicin—ovarian cancer	0.000302	0.000613	CcSEcCtD
Octreotide—Convulsion—Docetaxel—ovarian cancer	0.000302	0.000612	CcSEcCtD
Octreotide—Paraesthesia—Paclitaxel—ovarian cancer	0.000301	0.000611	CcSEcCtD
Octreotide—Hypertension—Docetaxel—ovarian cancer	0.000301	0.00061	CcSEcCtD
Octreotide—Drowsiness—Epirubicin—ovarian cancer	0.000301	0.00061	CcSEcCtD
Octreotide—Bronchitis—Doxorubicin—ovarian cancer	0.0003	0.000609	CcSEcCtD
Octreotide—Dyspnoea—Paclitaxel—ovarian cancer	0.000299	0.000607	CcSEcCtD
Octreotide—Somnolence—Paclitaxel—ovarian cancer	0.000298	0.000605	CcSEcCtD
Octreotide—Arthralgia—Docetaxel—ovarian cancer	0.000296	0.000602	CcSEcCtD
Octreotide—Chest pain—Docetaxel—ovarian cancer	0.000296	0.000602	CcSEcCtD
Octreotide—Myalgia—Docetaxel—ovarian cancer	0.000296	0.000602	CcSEcCtD
Octreotide—Nausea—Vinorelbine—ovarian cancer	0.000296	0.000601	CcSEcCtD
Octreotide—Dyspepsia—Paclitaxel—ovarian cancer	0.000295	0.000599	CcSEcCtD
Octreotide—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000295	0.000598	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000294	0.000597	CcSEcCtD
Octreotide—Jaundice—Epirubicin—ovarian cancer	0.000293	0.000594	CcSEcCtD
Octreotide—Urinary tract infection—Epirubicin—ovarian cancer	0.000292	0.000593	CcSEcCtD
Octreotide—Conjunctivitis—Epirubicin—ovarian cancer	0.000292	0.000593	CcSEcCtD
Octreotide—Dysuria—Doxorubicin—ovarian cancer	0.000292	0.000592	CcSEcCtD
Octreotide—Decreased appetite—Paclitaxel—ovarian cancer	0.000291	0.000591	CcSEcCtD
Octreotide—Dry mouth—Docetaxel—ovarian cancer	0.00029	0.000588	CcSEcCtD
Octreotide—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00029	0.000588	CcSEcCtD
Octreotide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000289	0.000587	CcSEcCtD
Octreotide—Fatigue—Paclitaxel—ovarian cancer	0.000289	0.000587	CcSEcCtD
Octreotide—Pollakiuria—Doxorubicin—ovarian cancer	0.000288	0.000585	CcSEcCtD
Octreotide—Pain—Paclitaxel—ovarian cancer	0.000287	0.000582	CcSEcCtD
Octreotide—Constipation—Paclitaxel—ovarian cancer	0.000287	0.000582	CcSEcCtD
Octreotide—Haematuria—Epirubicin—ovarian cancer	0.000287	0.000582	CcSEcCtD
Octreotide—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000284	0.000577	CcSEcCtD
Octreotide—Anaphylactic shock—Docetaxel—ovarian cancer	0.000284	0.000577	CcSEcCtD
Octreotide—Oedema—Docetaxel—ovarian cancer	0.000284	0.000577	CcSEcCtD
Octreotide—Weight increased—Doxorubicin—ovarian cancer	0.000284	0.000576	CcSEcCtD
Octreotide—Epistaxis—Epirubicin—ovarian cancer	0.000283	0.000575	CcSEcCtD
Octreotide—Infection—Docetaxel—ovarian cancer	0.000282	0.000573	CcSEcCtD
Octreotide—Weight decreased—Doxorubicin—ovarian cancer	0.000282	0.000573	CcSEcCtD
Octreotide—Sinusitis—Epirubicin—ovarian cancer	0.000282	0.000572	CcSEcCtD
Octreotide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000281	0.000571	CcSEcCtD
Octreotide—Pneumonia—Doxorubicin—ovarian cancer	0.00028	0.000568	CcSEcCtD
Octreotide—Shock—Docetaxel—ovarian cancer	0.00028	0.000567	CcSEcCtD
Octreotide—Nervous system disorder—Docetaxel—ovarian cancer	0.000279	0.000566	CcSEcCtD
Octreotide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000278	0.000565	CcSEcCtD
Octreotide—Drowsiness—Doxorubicin—ovarian cancer	0.000278	0.000564	CcSEcCtD
Octreotide—Tachycardia—Docetaxel—ovarian cancer	0.000277	0.000563	CcSEcCtD
Octreotide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000276	0.000561	CcSEcCtD
Octreotide—Skin disorder—Docetaxel—ovarian cancer	0.000276	0.00056	CcSEcCtD
Octreotide—Bradycardia—Epirubicin—ovarian cancer	0.000275	0.000557	CcSEcCtD
Octreotide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000274	0.000556	CcSEcCtD
Octreotide—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000273	0.000553	CcSEcCtD
Octreotide—Jaundice—Doxorubicin—ovarian cancer	0.000271	0.00055	CcSEcCtD
Octreotide—Anorexia—Docetaxel—ovarian cancer	0.000271	0.00055	CcSEcCtD
Octreotide—Rhinitis—Epirubicin—ovarian cancer	0.00027	0.000549	CcSEcCtD
Octreotide—Conjunctivitis—Doxorubicin—ovarian cancer	0.00027	0.000549	CcSEcCtD
Octreotide—Urinary tract infection—Doxorubicin—ovarian cancer	0.00027	0.000549	CcSEcCtD
Octreotide—Hepatitis—Epirubicin—ovarian cancer	0.00027	0.000547	CcSEcCtD
Octreotide—Hypoaesthesia—Epirubicin—ovarian cancer	0.000268	0.000545	CcSEcCtD
Octreotide—Pharyngitis—Epirubicin—ovarian cancer	0.000268	0.000543	CcSEcCtD
Octreotide—Urticaria—Paclitaxel—ovarian cancer	0.000266	0.000541	CcSEcCtD
Octreotide—Oedema peripheral—Epirubicin—ovarian cancer	0.000266	0.000539	CcSEcCtD
Octreotide—Haematuria—Doxorubicin—ovarian cancer	0.000265	0.000538	CcSEcCtD
Octreotide—Abdominal pain—Paclitaxel—ovarian cancer	0.000265	0.000538	CcSEcCtD
Octreotide—Body temperature increased—Paclitaxel—ovarian cancer	0.000265	0.000538	CcSEcCtD
Octreotide—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000263	0.000534	CcSEcCtD
Octreotide—Epistaxis—Doxorubicin—ovarian cancer	0.000262	0.000532	CcSEcCtD
Octreotide—Sinusitis—Doxorubicin—ovarian cancer	0.000261	0.000529	CcSEcCtD
Octreotide—Visual impairment—Epirubicin—ovarian cancer	0.00026	0.000528	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000259	0.000525	CcSEcCtD
Octreotide—Insomnia—Docetaxel—ovarian cancer	0.000257	0.000522	CcSEcCtD
Octreotide—Paraesthesia—Docetaxel—ovarian cancer	0.000255	0.000518	CcSEcCtD
Octreotide—Bradycardia—Doxorubicin—ovarian cancer	0.000254	0.000516	CcSEcCtD
Octreotide—Dyspnoea—Docetaxel—ovarian cancer	0.000253	0.000514	CcSEcCtD
Octreotide—Somnolence—Docetaxel—ovarian cancer	0.000253	0.000513	CcSEcCtD
Octreotide—Tinnitus—Epirubicin—ovarian cancer	0.000252	0.00051	CcSEcCtD
Octreotide—Flushing—Epirubicin—ovarian cancer	0.00025	0.000508	CcSEcCtD
Octreotide—Cardiac disorder—Epirubicin—ovarian cancer	0.00025	0.000508	CcSEcCtD
Octreotide—Rhinitis—Doxorubicin—ovarian cancer	0.00025	0.000508	CcSEcCtD
Octreotide—Dyspepsia—Docetaxel—ovarian cancer	0.00025	0.000508	CcSEcCtD
Octreotide—Hepatitis—Doxorubicin—ovarian cancer	0.00025	0.000507	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000248	0.000504	CcSEcCtD
Octreotide—Pharyngitis—Doxorubicin—ovarian cancer	0.000248	0.000503	CcSEcCtD
Octreotide—Decreased appetite—Docetaxel—ovarian cancer	0.000247	0.000501	CcSEcCtD
Octreotide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000247	0.000501	CcSEcCtD
Octreotide—Oedema peripheral—Doxorubicin—ovarian cancer	0.000246	0.000499	CcSEcCtD
Octreotide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000245	0.000498	CcSEcCtD
Octreotide—Fatigue—Docetaxel—ovarian cancer	0.000245	0.000497	CcSEcCtD
Octreotide—Immune system disorder—Epirubicin—ovarian cancer	0.000244	0.000495	CcSEcCtD
Octreotide—Constipation—Docetaxel—ovarian cancer	0.000243	0.000493	CcSEcCtD
Octreotide—Pain—Docetaxel—ovarian cancer	0.000243	0.000493	CcSEcCtD
Octreotide—Arrhythmia—Epirubicin—ovarian cancer	0.000241	0.000489	CcSEcCtD
Octreotide—Visual impairment—Doxorubicin—ovarian cancer	0.000241	0.000488	CcSEcCtD
Octreotide—Asthenia—Paclitaxel—ovarian cancer	0.000241	0.000488	CcSEcCtD
Octreotide—Alopecia—Epirubicin—ovarian cancer	0.000238	0.000484	CcSEcCtD
Octreotide—Pruritus—Paclitaxel—ovarian cancer	0.000237	0.000481	CcSEcCtD
Octreotide—Mental disorder—Epirubicin—ovarian cancer	0.000236	0.00048	CcSEcCtD
Octreotide—Malnutrition—Epirubicin—ovarian cancer	0.000235	0.000477	CcSEcCtD
Octreotide—Erythema—Epirubicin—ovarian cancer	0.000235	0.000477	CcSEcCtD
Octreotide—Feeling abnormal—Docetaxel—ovarian cancer	0.000234	0.000475	CcSEcCtD
Octreotide—Tinnitus—Doxorubicin—ovarian cancer	0.000233	0.000472	CcSEcCtD
Octreotide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000232	0.000472	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000232	0.00047	CcSEcCtD
Octreotide—Flushing—Doxorubicin—ovarian cancer	0.000232	0.00047	CcSEcCtD
Octreotide—Flatulence—Epirubicin—ovarian cancer	0.000231	0.00047	CcSEcCtD
Octreotide—Tension—Epirubicin—ovarian cancer	0.00023	0.000468	CcSEcCtD
Octreotide—Diarrhoea—Paclitaxel—ovarian cancer	0.000229	0.000466	CcSEcCtD
Octreotide—Nervousness—Epirubicin—ovarian cancer	0.000228	0.000463	CcSEcCtD
Octreotide—Back pain—Epirubicin—ovarian cancer	0.000227	0.000461	CcSEcCtD
Octreotide—Muscle spasms—Epirubicin—ovarian cancer	0.000226	0.000458	CcSEcCtD
Octreotide—Immune system disorder—Doxorubicin—ovarian cancer	0.000225	0.000458	CcSEcCtD
Octreotide—Abdominal pain—Docetaxel—ovarian cancer	0.000225	0.000456	CcSEcCtD
Octreotide—Body temperature increased—Docetaxel—ovarian cancer	0.000225	0.000456	CcSEcCtD
Octreotide—Arrhythmia—Doxorubicin—ovarian cancer	0.000223	0.000453	CcSEcCtD
Octreotide—Dizziness—Paclitaxel—ovarian cancer	0.000222	0.00045	CcSEcCtD
Octreotide—Vision blurred—Epirubicin—ovarian cancer	0.000221	0.000449	CcSEcCtD
Octreotide—Alopecia—Doxorubicin—ovarian cancer	0.000221	0.000448	CcSEcCtD
Octreotide—Mental disorder—Doxorubicin—ovarian cancer	0.000219	0.000444	CcSEcCtD
Octreotide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000218	0.000442	CcSEcCtD
Octreotide—Erythema—Doxorubicin—ovarian cancer	0.000217	0.000441	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—ovarian cancer	0.000217	0.000441	CcSEcCtD
Octreotide—Anaemia—Epirubicin—ovarian cancer	0.000217	0.000441	CcSEcCtD
Octreotide—Agitation—Epirubicin—ovarian cancer	0.000216	0.000438	CcSEcCtD
Octreotide—Flatulence—Doxorubicin—ovarian cancer	0.000214	0.000435	CcSEcCtD
Octreotide—Tension—Doxorubicin—ovarian cancer	0.000213	0.000433	CcSEcCtD
Octreotide—Vomiting—Paclitaxel—ovarian cancer	0.000213	0.000433	CcSEcCtD
Octreotide—Malaise—Epirubicin—ovarian cancer	0.000212	0.00043	CcSEcCtD
Octreotide—Rash—Paclitaxel—ovarian cancer	0.000211	0.000429	CcSEcCtD
Octreotide—Dermatitis—Paclitaxel—ovarian cancer	0.000211	0.000429	CcSEcCtD
Octreotide—Nervousness—Doxorubicin—ovarian cancer	0.000211	0.000428	CcSEcCtD
Octreotide—Vertigo—Epirubicin—ovarian cancer	0.000211	0.000428	CcSEcCtD
Octreotide—Syncope—Epirubicin—ovarian cancer	0.000211	0.000427	CcSEcCtD
Octreotide—Back pain—Doxorubicin—ovarian cancer	0.00021	0.000427	CcSEcCtD
Octreotide—Headache—Paclitaxel—ovarian cancer	0.00021	0.000426	CcSEcCtD
Octreotide—Hypersensitivity—Docetaxel—ovarian cancer	0.000209	0.000425	CcSEcCtD
Octreotide—Muscle spasms—Doxorubicin—ovarian cancer	0.000209	0.000424	CcSEcCtD
Octreotide—Palpitations—Epirubicin—ovarian cancer	0.000208	0.000421	CcSEcCtD
Octreotide—Loss of consciousness—Epirubicin—ovarian cancer	0.000206	0.000419	CcSEcCtD
Octreotide—Cough—Epirubicin—ovarian cancer	0.000205	0.000416	CcSEcCtD
Octreotide—Vision blurred—Doxorubicin—ovarian cancer	0.000205	0.000416	CcSEcCtD
Octreotide—Asthenia—Docetaxel—ovarian cancer	0.000204	0.000414	CcSEcCtD
Octreotide—Convulsion—Epirubicin—ovarian cancer	0.000203	0.000413	CcSEcCtD
Octreotide—Hypertension—Epirubicin—ovarian cancer	0.000203	0.000411	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000202	0.000409	CcSEcCtD
Octreotide—Pruritus—Docetaxel—ovarian cancer	0.000201	0.000408	CcSEcCtD
Octreotide—Anaemia—Doxorubicin—ovarian cancer	0.000201	0.000408	CcSEcCtD
Octreotide—Chest pain—Epirubicin—ovarian cancer	0.0002	0.000406	CcSEcCtD
Octreotide—Arthralgia—Epirubicin—ovarian cancer	0.0002	0.000406	CcSEcCtD
Octreotide—Myalgia—Epirubicin—ovarian cancer	0.0002	0.000406	CcSEcCtD
Octreotide—Agitation—Doxorubicin—ovarian cancer	0.0002	0.000405	CcSEcCtD
Octreotide—Anxiety—Epirubicin—ovarian cancer	0.000199	0.000404	CcSEcCtD
Octreotide—Nausea—Paclitaxel—ovarian cancer	0.000199	0.000404	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000199	0.000403	CcSEcCtD
Octreotide—Discomfort—Epirubicin—ovarian cancer	0.000198	0.000401	CcSEcCtD
Octreotide—Malaise—Doxorubicin—ovarian cancer	0.000196	0.000398	CcSEcCtD
Octreotide—Dry mouth—Epirubicin—ovarian cancer	0.000196	0.000397	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—ovarian cancer	0.000195	0.000396	CcSEcCtD
Octreotide—Syncope—Doxorubicin—ovarian cancer	0.000195	0.000395	CcSEcCtD
Octreotide—Diarrhoea—Docetaxel—ovarian cancer	0.000194	0.000395	CcSEcCtD
Octreotide—Palpitations—Doxorubicin—ovarian cancer	0.000192	0.00039	CcSEcCtD
Octreotide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000192	0.000389	CcSEcCtD
Octreotide—Oedema—Epirubicin—ovarian cancer	0.000192	0.000389	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—ovarian cancer	0.000191	0.000388	CcSEcCtD
Octreotide—Infection—Epirubicin—ovarian cancer	0.00019	0.000386	CcSEcCtD
Octreotide—Cough—Doxorubicin—ovarian cancer	0.00019	0.000385	CcSEcCtD
Octreotide—Shock—Epirubicin—ovarian cancer	0.000189	0.000383	CcSEcCtD
Octreotide—Convulsion—Doxorubicin—ovarian cancer	0.000188	0.000382	CcSEcCtD
Octreotide—Nervous system disorder—Epirubicin—ovarian cancer	0.000188	0.000381	CcSEcCtD
Octreotide—Dizziness—Docetaxel—ovarian cancer	0.000188	0.000381	CcSEcCtD
Octreotide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000188	0.000381	CcSEcCtD
Octreotide—Hypertension—Doxorubicin—ovarian cancer	0.000188	0.000381	CcSEcCtD
Octreotide—Tachycardia—Epirubicin—ovarian cancer	0.000187	0.00038	CcSEcCtD
Octreotide—Skin disorder—Epirubicin—ovarian cancer	0.000186	0.000378	CcSEcCtD
Octreotide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000185	0.000376	CcSEcCtD
Octreotide—Myalgia—Doxorubicin—ovarian cancer	0.000185	0.000375	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—ovarian cancer	0.000185	0.000375	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—ovarian cancer	0.000185	0.000375	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—ovarian cancer	0.000184	0.000374	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000184	0.000373	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—ovarian cancer	0.000183	0.000371	CcSEcCtD
Octreotide—Anorexia—Epirubicin—ovarian cancer	0.000183	0.000371	CcSEcCtD
Octreotide—Dry mouth—Doxorubicin—ovarian cancer	0.000181	0.000367	CcSEcCtD
Octreotide—Vomiting—Docetaxel—ovarian cancer	0.000181	0.000367	CcSEcCtD
Octreotide—Rash—Docetaxel—ovarian cancer	0.000179	0.000364	CcSEcCtD
Octreotide—Dermatitis—Docetaxel—ovarian cancer	0.000179	0.000363	CcSEcCtD
Octreotide—Headache—Docetaxel—ovarian cancer	0.000178	0.000361	CcSEcCtD
Octreotide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000177	0.00036	CcSEcCtD
Octreotide—Oedema—Doxorubicin—ovarian cancer	0.000177	0.00036	CcSEcCtD
Octreotide—Infection—Doxorubicin—ovarian cancer	0.000176	0.000358	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000175	0.000354	CcSEcCtD
Octreotide—Shock—Doxorubicin—ovarian cancer	0.000174	0.000354	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000174	0.000353	CcSEcCtD
Octreotide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000174	0.000352	CcSEcCtD
Octreotide—Insomnia—Epirubicin—ovarian cancer	0.000173	0.000352	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—ovarian cancer	0.000173	0.000351	CcSEcCtD
Octreotide—Skin disorder—Doxorubicin—ovarian cancer	0.000172	0.00035	CcSEcCtD
Octreotide—Paraesthesia—Epirubicin—ovarian cancer	0.000172	0.000349	CcSEcCtD
Octreotide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000171	0.000348	CcSEcCtD
Octreotide—Dyspnoea—Epirubicin—ovarian cancer	0.000171	0.000347	CcSEcCtD
Octreotide—Somnolence—Epirubicin—ovarian cancer	0.00017	0.000346	CcSEcCtD
Octreotide—Anorexia—Doxorubicin—ovarian cancer	0.000169	0.000343	CcSEcCtD
Octreotide—Nausea—Docetaxel—ovarian cancer	0.000169	0.000343	CcSEcCtD
Octreotide—Dyspepsia—Epirubicin—ovarian cancer	0.000169	0.000342	CcSEcCtD
Octreotide—Decreased appetite—Epirubicin—ovarian cancer	0.000167	0.000338	CcSEcCtD
Octreotide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000165	0.000336	CcSEcCtD
Octreotide—Fatigue—Epirubicin—ovarian cancer	0.000165	0.000335	CcSEcCtD
Octreotide—Pain—Epirubicin—ovarian cancer	0.000164	0.000333	CcSEcCtD
Octreotide—Constipation—Epirubicin—ovarian cancer	0.000164	0.000333	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000162	0.000328	CcSEcCtD
Octreotide—Insomnia—Doxorubicin—ovarian cancer	0.00016	0.000326	CcSEcCtD
Octreotide—Paraesthesia—Doxorubicin—ovarian cancer	0.000159	0.000323	CcSEcCtD
Octreotide—Dyspnoea—Doxorubicin—ovarian cancer	0.000158	0.000321	CcSEcCtD
Octreotide—Feeling abnormal—Epirubicin—ovarian cancer	0.000158	0.000321	CcSEcCtD
Octreotide—Somnolence—Doxorubicin—ovarian cancer	0.000158	0.00032	CcSEcCtD
Octreotide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000157	0.000318	CcSEcCtD
Octreotide—Dyspepsia—Doxorubicin—ovarian cancer	0.000156	0.000317	CcSEcCtD
Octreotide—Decreased appetite—Doxorubicin—ovarian cancer	0.000154	0.000313	CcSEcCtD
Octreotide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000153	0.000311	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—ovarian cancer	0.000153	0.00031	CcSEcCtD
Octreotide—Urticaria—Epirubicin—ovarian cancer	0.000152	0.000309	CcSEcCtD
Octreotide—Pain—Doxorubicin—ovarian cancer	0.000152	0.000308	CcSEcCtD
Octreotide—Constipation—Doxorubicin—ovarian cancer	0.000152	0.000308	CcSEcCtD
Octreotide—Body temperature increased—Epirubicin—ovarian cancer	0.000152	0.000307	CcSEcCtD
Octreotide—Abdominal pain—Epirubicin—ovarian cancer	0.000152	0.000307	CcSEcCtD
Octreotide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000146	0.000297	CcSEcCtD
Octreotide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000145	0.000294	CcSEcCtD
Octreotide—Hypersensitivity—Epirubicin—ovarian cancer	0.000141	0.000287	CcSEcCtD
Octreotide—Urticaria—Doxorubicin—ovarian cancer	0.000141	0.000286	CcSEcCtD
Octreotide—Body temperature increased—Doxorubicin—ovarian cancer	0.00014	0.000285	CcSEcCtD
Octreotide—Abdominal pain—Doxorubicin—ovarian cancer	0.00014	0.000285	CcSEcCtD
Octreotide—Asthenia—Epirubicin—ovarian cancer	0.000138	0.000279	CcSEcCtD
Octreotide—Pruritus—Epirubicin—ovarian cancer	0.000136	0.000275	CcSEcCtD
Octreotide—Diarrhoea—Epirubicin—ovarian cancer	0.000131	0.000266	CcSEcCtD
Octreotide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000131	0.000265	CcSEcCtD
Octreotide—Asthenia—Doxorubicin—ovarian cancer	0.000127	0.000258	CcSEcCtD
Octreotide—Dizziness—Epirubicin—ovarian cancer	0.000127	0.000257	CcSEcCtD
Octreotide—Pruritus—Doxorubicin—ovarian cancer	0.000125	0.000255	CcSEcCtD
Octreotide—Vomiting—Epirubicin—ovarian cancer	0.000122	0.000247	CcSEcCtD
Octreotide—Diarrhoea—Doxorubicin—ovarian cancer	0.000121	0.000246	CcSEcCtD
Octreotide—Rash—Epirubicin—ovarian cancer	0.000121	0.000245	CcSEcCtD
Octreotide—Dermatitis—Epirubicin—ovarian cancer	0.000121	0.000245	CcSEcCtD
Octreotide—Headache—Epirubicin—ovarian cancer	0.00012	0.000244	CcSEcCtD
Octreotide—Dizziness—Doxorubicin—ovarian cancer	0.000117	0.000238	CcSEcCtD
Octreotide—Nausea—Epirubicin—ovarian cancer	0.000114	0.000231	CcSEcCtD
Octreotide—Vomiting—Doxorubicin—ovarian cancer	0.000113	0.000229	CcSEcCtD
Octreotide—Rash—Doxorubicin—ovarian cancer	0.000112	0.000227	CcSEcCtD
Octreotide—Dermatitis—Doxorubicin—ovarian cancer	0.000112	0.000227	CcSEcCtD
Octreotide—Headache—Doxorubicin—ovarian cancer	0.000111	0.000225	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PGR—ovarian cancer	0.000109	0.00207	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—ovarian cancer	0.000105	0.000214	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—IL6ST—ovarian cancer	0.000105	0.002	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PPP2R1A—ovarian cancer	0.000104	0.00199	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CD—ovarian cancer	0.000104	0.00199	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000102	0.00195	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CAV1—ovarian cancer	0.000101	0.00193	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PARP1—ovarian cancer	0.000101	0.00193	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CG—ovarian cancer	0.000101	0.00192	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PPP2R1A—ovarian cancer	0.0001	0.00191	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CB—ovarian cancer	9.98e-05	0.00191	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CD—ovarian cancer	9.97e-05	0.0019	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ESR1—ovarian cancer	9.76e-05	0.00186	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CD—ovarian cancer	9.74e-05	0.00186	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6ST—ovarian cancer	9.66e-05	0.00184	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6ST—ovarian cancer	9.6e-05	0.00183	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCL8—ovarian cancer	9.6e-05	0.00183	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CB—ovarian cancer	9.57e-05	0.00183	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CG—ovarian cancer	9.29e-05	0.00177	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APC—ovarian cancer	9.22e-05	0.00176	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CG—ovarian cancer	9.22e-05	0.00176	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—NRAS—ovarian cancer	9.22e-05	0.00176	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL8—ovarian cancer	9.2e-05	0.00176	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL2—ovarian cancer	9.17e-05	0.00175	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CB—ovarian cancer	9.07e-05	0.00173	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CD—ovarian cancer	8.99e-05	0.00172	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PPP2R1A—ovarian cancer	8.88e-05	0.00169	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CD—ovarian cancer	8.85e-05	0.00169	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—MAPK3—ovarian cancer	8.83e-05	0.00169	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2—ovarian cancer	8.79e-05	0.00168	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL8—ovarian cancer	8.71e-05	0.00166	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CB—ovarian cancer	8.69e-05	0.00166	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CB—ovarian cancer	8.49e-05	0.00162	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—MAPK1—ovarian cancer	8.41e-05	0.0016	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EGFR—ovarian cancer	8.4e-05	0.0016	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL8—ovarian cancer	8.35e-05	0.00159	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL2—ovarian cancer	8.33e-05	0.00159	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TERT—ovarian cancer	8.3e-05	0.00158	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PPP2R1A—ovarian cancer	8.2e-05	0.00156	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CD—ovarian cancer	8.16e-05	0.00156	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL8—ovarian cancer	8.16e-05	0.00156	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CD—ovarian cancer	8.11e-05	0.00155	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—PIK3CA—ovarian cancer	8.03e-05	0.00153	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2—ovarian cancer	7.98e-05	0.00152	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TERT—ovarian cancer	7.95e-05	0.00152	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—KRAS—ovarian cancer	7.94e-05	0.00152	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CB—ovarian cancer	7.84e-05	0.0015	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—ovarian cancer	7.8e-05	0.00149	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CB—ovarian cancer	7.71e-05	0.00147	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CAV1—ovarian cancer	7.67e-05	0.00146	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL8—ovarian cancer	7.53e-05	0.00144	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL8—ovarian cancer	7.41e-05	0.00141	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ESR1—ovarian cancer	7.39e-05	0.00141	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CAV1—ovarian cancer	7.36e-05	0.0014	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PIK3CA—ovarian cancer	7.29e-05	0.00139	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6ST—ovarian cancer	7.28e-05	0.00139	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—ovarian cancer	7.2e-05	0.00137	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ERBB2—ovarian cancer	7.16e-05	0.00137	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CB—ovarian cancer	7.12e-05	0.00136	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ESR1—ovarian cancer	7.09e-05	0.00135	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—ovarian cancer	7.08e-05	0.00135	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MTOR—ovarian cancer	7.07e-05	0.00135	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CB—ovarian cancer	7.07e-05	0.00135	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TERT—ovarian cancer	7.05e-05	0.00135	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APC—ovarian cancer	6.99e-05	0.00133	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CG—ovarian cancer	6.99e-05	0.00133	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—NRAS—ovarian cancer	6.99e-05	0.00133	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6ST—ovarian cancer	6.97e-05	0.00133	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL8—ovarian cancer	6.84e-05	0.0013	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL8—ovarian cancer	6.79e-05	0.0013	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HRAS—ovarian cancer	6.75e-05	0.00129	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CG—ovarian cancer	6.7e-05	0.00128	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APC—ovarian cancer	6.7e-05	0.00128	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—NRAS—ovarian cancer	6.7e-05	0.00128	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK3—ovarian cancer	6.69e-05	0.00128	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1B—ovarian cancer	6.63e-05	0.00127	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—ovarian cancer	6.56e-05	0.00125	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—ovarian cancer	6.53e-05	0.00125	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CAV1—ovarian cancer	6.53e-05	0.00125	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TERT—ovarian cancer	6.51e-05	0.00124	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—ovarian cancer	6.5e-05	0.00124	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—ovarian cancer	6.49e-05	0.00124	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—ovarian cancer	6.46e-05	0.00123	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK3—ovarian cancer	6.42e-05	0.00122	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK1—ovarian cancer	6.37e-05	0.00122	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—ovarian cancer	6.37e-05	0.00122	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCND1—ovarian cancer	6.33e-05	0.00121	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ESR1—ovarian cancer	6.29e-05	0.0012	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—ovarian cancer	6.27e-05	0.0012	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6ST—ovarian cancer	6.19e-05	0.00118	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CD—ovarian cancer	6.15e-05	0.00117	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—ovarian cancer	6.14e-05	0.00117	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTEN—ovarian cancer	6.11e-05	0.00117	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK1—ovarian cancer	6.11e-05	0.00117	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—ovarian cancer	6.11e-05	0.00117	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PIK3CA—ovarian cancer	6.09e-05	0.00116	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CAV1—ovarian cancer	6.02e-05	0.00115	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—KRAS—ovarian cancer	6.02e-05	0.00115	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKT1—ovarian cancer	5.96e-05	0.00114	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APC—ovarian cancer	5.94e-05	0.00113	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CG—ovarian cancer	5.94e-05	0.00113	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—NRAS—ovarian cancer	5.94e-05	0.00113	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CD—ovarian cancer	5.89e-05	0.00112	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PIK3CA—ovarian cancer	5.84e-05	0.00111	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ESR1—ovarian cancer	5.8e-05	0.00111	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—ovarian cancer	5.77e-05	0.0011	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6ST—ovarian cancer	5.71e-05	0.00109	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK3—ovarian cancer	5.69e-05	0.00109	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PIK3CA—ovarian cancer	5.53e-05	0.00105	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—ovarian cancer	5.52e-05	0.00105	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APC—ovarian cancer	5.49e-05	0.00105	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CG—ovarian cancer	5.49e-05	0.00105	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—NRAS—ovarian cancer	5.49e-05	0.00105	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—ovarian cancer	5.46e-05	0.00104	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NRAS—ovarian cancer	5.45e-05	0.00104	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ERBB2—ovarian cancer	5.43e-05	0.00104	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK1—ovarian cancer	5.42e-05	0.00103	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—ovarian cancer	5.42e-05	0.00103	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTOR—ovarian cancer	5.36e-05	0.00102	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CB—ovarian cancer	5.36e-05	0.00102	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PIK3CA—ovarian cancer	5.3e-05	0.00101	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK3—ovarian cancer	5.25e-05	0.001	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CD—ovarian cancer	5.23e-05	0.000997	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK3—ovarian cancer	5.22e-05	0.000996	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ERBB2—ovarian cancer	5.2e-05	0.000993	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PIK3CA—ovarian cancer	5.18e-05	0.000988	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL8—ovarian cancer	5.15e-05	0.000982	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MTOR—ovarian cancer	5.14e-05	0.00098	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CB—ovarian cancer	5.14e-05	0.00098	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—ovarian cancer	5.12e-05	0.000976	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—ovarian cancer	5.11e-05	0.000976	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—ovarian cancer	5.08e-05	0.000969	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1B—ovarian cancer	5.03e-05	0.000959	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK1—ovarian cancer	5e-05	0.000954	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—ovarian cancer	5e-05	0.000954	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—ovarian cancer	4.97e-05	0.000949	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK1—ovarian cancer	4.97e-05	0.000948	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—ovarian cancer	4.96e-05	0.000947	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL8—ovarian cancer	4.93e-05	0.000942	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—ovarian cancer	4.93e-05	0.00094	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—ovarian cancer	4.92e-05	0.000939	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—ovarian cancer	4.9e-05	0.000936	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—ovarian cancer	4.89e-05	0.000934	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CD—ovarian cancer	4.82e-05	0.00092	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1B—ovarian cancer	4.82e-05	0.00092	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—ovarian cancer	4.8e-05	0.000915	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PIK3CA—ovarian cancer	4.78e-05	0.000912	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—ovarian cancer	4.77e-05	0.00091	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—ovarian cancer	4.75e-05	0.000906	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—ovarian cancer	4.72e-05	0.000901	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—ovarian cancer	4.72e-05	0.000901	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—ovarian cancer	4.72e-05	0.0009	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PIK3CA—ovarian cancer	4.7e-05	0.000897	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—ovarian cancer	4.69e-05	0.000896	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—ovarian cancer	4.69e-05	0.000895	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—ovarian cancer	4.66e-05	0.000888	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTEN—ovarian cancer	4.63e-05	0.000883	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ERBB2—ovarian cancer	4.62e-05	0.000881	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—ovarian cancer	4.6e-05	0.000877	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTOR—ovarian cancer	4.55e-05	0.000869	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CB—ovarian cancer	4.55e-05	0.000869	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—ovarian cancer	4.55e-05	0.000869	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—ovarian cancer	4.52e-05	0.000862	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—ovarian cancer	4.46e-05	0.000852	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTEN—ovarian cancer	4.44e-05	0.000847	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL8—ovarian cancer	4.38e-05	0.000835	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—ovarian cancer	4.35e-05	0.00083	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PIK3CA—ovarian cancer	4.34e-05	0.000828	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—ovarian cancer	4.33e-05	0.000826	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PIK3CA—ovarian cancer	4.31e-05	0.000822	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1B—ovarian cancer	4.27e-05	0.000816	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ERBB2—ovarian cancer	4.26e-05	0.000813	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—ovarian cancer	4.23e-05	0.000807	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTOR—ovarian cancer	4.2e-05	0.000802	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CB—ovarian cancer	4.2e-05	0.000802	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—ovarian cancer	4.19e-05	0.000799	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—ovarian cancer	4.18e-05	0.000798	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—ovarian cancer	4.18e-05	0.000798	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—ovarian cancer	4.17e-05	0.000795	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—ovarian cancer	4.16e-05	0.000794	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—ovarian cancer	4.14e-05	0.00079	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NRAS—ovarian cancer	4.13e-05	0.000788	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—ovarian cancer	4.08e-05	0.000778	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL8—ovarian cancer	4.04e-05	0.000771	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—ovarian cancer	4.04e-05	0.000771	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—ovarian cancer	4.01e-05	0.000766	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—ovarian cancer	4.01e-05	0.000765	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—ovarian cancer	3.99e-05	0.000761	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—ovarian cancer	3.97e-05	0.000757	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NRAS—ovarian cancer	3.96e-05	0.000756	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—ovarian cancer	3.96e-05	0.000755	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK3—ovarian cancer	3.95e-05	0.000755	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1B—ovarian cancer	3.94e-05	0.000753	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTEN—ovarian cancer	3.94e-05	0.000751	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—ovarian cancer	3.9e-05	0.000745	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—ovarian cancer	3.87e-05	0.000738	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—ovarian cancer	3.86e-05	0.000737	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—ovarian cancer	3.85e-05	0.000734	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—ovarian cancer	3.84e-05	0.000733	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—ovarian cancer	3.84e-05	0.000733	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—ovarian cancer	3.82e-05	0.000728	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK3—ovarian cancer	3.79e-05	0.000724	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—ovarian cancer	3.76e-05	0.000718	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK1—ovarian cancer	3.76e-05	0.000718	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—ovarian cancer	3.76e-05	0.000718	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—ovarian cancer	3.73e-05	0.000711	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—ovarian cancer	3.69e-05	0.000704	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—ovarian cancer	3.65e-05	0.000697	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTEN—ovarian cancer	3.63e-05	0.000693	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK1—ovarian cancer	3.61e-05	0.000688	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—ovarian cancer	3.61e-05	0.000688	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—ovarian cancer	3.55e-05	0.000678	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—ovarian cancer	3.55e-05	0.000678	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—ovarian cancer	3.54e-05	0.000676	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—ovarian cancer	3.52e-05	0.000672	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—ovarian cancer	3.52e-05	0.000672	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRAS—ovarian cancer	3.51e-05	0.00067	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—ovarian cancer	3.41e-05	0.00065	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK3—ovarian cancer	3.36e-05	0.000642	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—ovarian cancer	3.28e-05	0.000626	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—ovarian cancer	3.27e-05	0.000624	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PIK3CA—ovarian cancer	3.27e-05	0.000623	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—ovarian cancer	3.25e-05	0.00062	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NRAS—ovarian cancer	3.24e-05	0.000618	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK1—ovarian cancer	3.2e-05	0.000611	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—ovarian cancer	3.2e-05	0.00061	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—ovarian cancer	3.16e-05	0.000603	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PIK3CA—ovarian cancer	3.13e-05	0.000597	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK3—ovarian cancer	3.1e-05	0.000592	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—ovarian cancer	3.03e-05	0.000578	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—ovarian cancer	3.02e-05	0.000577	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—ovarian cancer	3.02e-05	0.000577	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—ovarian cancer	3.02e-05	0.000576	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK1—ovarian cancer	2.95e-05	0.000564	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—ovarian cancer	2.95e-05	0.000563	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—ovarian cancer	2.9e-05	0.000553	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—ovarian cancer	2.89e-05	0.000552	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—ovarian cancer	2.79e-05	0.000532	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PIK3CA—ovarian cancer	2.78e-05	0.00053	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—ovarian cancer	2.77e-05	0.000529	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—ovarian cancer	2.69e-05	0.000513	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—ovarian cancer	2.67e-05	0.000509	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—ovarian cancer	2.57e-05	0.00049	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PIK3CA—ovarian cancer	2.56e-05	0.000489	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—ovarian cancer	2.56e-05	0.000488	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—ovarian cancer	2.48e-05	0.000473	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—ovarian cancer	2.46e-05	0.000469	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—ovarian cancer	2.37e-05	0.000452	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—ovarian cancer	2.27e-05	0.000433	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—ovarian cancer	2.27e-05	0.000433	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—ovarian cancer	2.09e-05	0.000399	CbGpPWpGaD
